Roche's Gazyva Now a Breakthrough Therapy for Lupus Nephritis - Yahoo Finance
Roche's Gazyva Now a Breakthrough Therapy for Lupus Nephritis Yahoo Finance
Roche's (RHHBY) lymphoma drug, Gazyva, obtains Breakthrough Therapy designation in the United States for lupus nephritis.
Comments
Post a Comment